Key result
Corticosteroid therapy decreases elevated eosinophils and ECP levels in a pediatric eosinophilic myocarditis case.
Why the study?
Serum eosinophilic cationic protein (ECP) is used to monitor inflammatory activity and treatment effects in adult eosinophilic myocarditis, but its usefulness in pediatric patients is unclear.
Is serum eosinophilic cationic protein (ECP) useful to monitor the efficacy of corticosteroid treatment in a pediatric patient with eosinophilic myocarditis?
Case Report (n=1)
Is serum eosinophilic cationic protein (ECP) useful to monitor the efficacy of corticosteroid treatment in a pediatric patient with eosinophilic myocarditis?
Serum eosinophilic cationic protein (ECP) is a useful biomarker to monitor the efficacy of corticosteroid treatment in pediatric patients with eosinophilic myocarditis.
Supports monitoring serum ECP during corticosteroid therapy for pediatric eosinophilic myocarditis; leaves open prospective confirmation in larger cohorts.
Eosinophilic myocarditis is characterized by an acute inflammatory infiltration of eosinophils in the myocardium. Diagnosis is confirmed by a heart muscle biopsy. Immunopathological studies suggest that several toxic proteins, such as eosinophilic cationic protein (ECP) derived from the degranulation of eosinophils, may play an important role in the patho- genesis of this cardiac disorder. Serum levels of ECP, which are related to the inflammatory activity of the disease are used to monitor and determine the effects of treatment in adult patients. Herein, we present the case of a 12-year-old, previously healthy, junior high school girl with eosinophilic myocarditis. The diagnosis was confirmed by a myocardial biopsy and the patient was treated successfully with prednisolone. On admission, her peripheral blood eosinophil count (3342 /μL) and serum ECP level (124 μg/L) were extremely high, but both decreased significantly during corticosteroid therapy. In the present case, corticosteroid treatment was successful and early diagnosis by endomyocardial biopsy is recommended. Furthermore, serum ECP is useful to monitor the efficacy of treatment in pediatric patients.
No takes yet. Share an insight, caveat, or question.
Ito et al. (2003) conducted a case report in Eosinophilic myocarditis (n=1). Prednisolone was evaluated on Peripheral blood eosinophil count and serum ECP level. In a 12-year-old girl with eosinophilic myocarditis, corticosteroid therapy successfully decreased extremely high peripheral blood eosinophil count (3342 /μL) and serum ECP level (124 μg/L).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: